Addictions and the associated public health problems of HIV transmission, crime and violence, exact a severe toll on our nation, costing billions annually in health care, lost productivity, and incarceration. As there have been rapid advances in neuroscience and genetics in the past two decades, we need to speed the 'forward'translation of this knowledge into more effective clinical treatments for the addictions. Conversely, for addiction treatments with some known efficacy, we can now apply new neuroscience and genetic tools in 'backward-translation'-- e.g., finding why a treatment works well for some individuals, yet not at all for others. To help meet the need for skilled translatioal researchers, this application proposes a continuation of our T32 Translational Addiction Research Fellowship for pre- and post-doctoral trainees at the University of Pennsylvania. The training program will make explicit a long-standing translational tradition at Penn, integrating clinical and basic research strengths to create trainees, whether clinical or preclinical, Ph.D.'s or M.D.s, who will be able to accelerate addiction science in the next decade. The emphasis on translation is reflected at each level of the program - through the Co-PIs (clinical and basic, Drs. Childress and Pierce), the internal and external advisory board members, the formal didactics, the """"""""dual"""""""" mentoring (each trainee will have both a clinical and preclinical mentor), and in the focus of trainees'mentored research projects. The translational emphasis of the program is driven by the recognition that addictions are complex disorders, multi-determined by interaction of genetic vulnerabilities, exposure to drug, and a host of modulating (e.g., early trauma, stress, cultural norms) influences. Trainees will thus be offered state-of-the-art knowledge about these interacting determinants through a didactic series specific to the program, and through mentored projects that may range from molecular and genetic studies, to brain systems (neuroscience and neuroimaging), to clinical treatment trials, and drug policy. This wide range of choices is enabled by the long history of excellence in addiction research at the University, reflected in the several academic research Centers (Penn-VA Addiction Research Center~ Translational Research Laboratories/CNB~ Center for Aids Research~ Transdisciplinary Tobacco Use Research Center~ Treatment Research Institute) and laboratories (Lucki lab, Mackler lab) offering skilled, successful mentors to the Fellowship. Mentored research also takes place within several affiliated treatment settings (VA, Presby-Penn, NIDA CTN sites, community methadone clinics, and mobile HIV Prevention units), critical for translating new research findings into the 'real world'. Public Health Relevance: The addictions are complex and expensive public health problems for which we need more effective treatments. The proposed T32 Translational Addiction Research Fellowship will give trainees the framework, and the skills, to speed the development of effective addiction treatments - with concomitant benefit for the addiction-linked public health problems of violence, crime and HIV/AIDs.
The addictions are complex and expensive public health problems for which we need more effective treatments. The proposed T32 Translational Addiction Research Fellowship will give trainees the framework, and the skills, to speed the development of effective addiction treatments - with concomitant benefit for the addiction-linked public health problems of violence, crime and HIV/AIDs. PUBLIC HEALTH RELEVANCE: The proposed continuation of a recently-funded T32 Translational Addiction Research Fellowship at the University of Pennsylvania will give 4 pre-doctoral and 4 post-doctoral trainees the framework, and the skills, to speed the next generation of effective addiction treatments - with concomitant benefit for the addiction-linked public health problems of violence, crime and HIV/AIDs.
|Swinford-Jackson, Sarah E; Pierce, R Christopher (2018) Harmony and heresy of an L-type calcium channel inhibitor: suppression of cocaine seeking via increased dopamine transmission in the nucleus accumbens. Neuropsychopharmacology 43:2335-2336|
|Reilly, Sean W; Puentes, Laura N; Schmitz, Alexander et al. (2018) Synthesis and evaluation of an AZD2461 [18F]PET probe in non-human primates reveals the PARP-1 inhibitor to be non-blood-brain barrier penetrant. Bioorg Chem 83:242-249|
|An, Sieun; Han, Xiaochun; Wu, Bing et al. (2018) Neural activation in response to the two sides of emotion. Neurosci Lett 684:140-144|
|Manners, M T; Yohn, N L; Lahens, N F et al. (2018) Transgenerational inheritance of chronic adolescent stress: Effects of stress response and the amygdala transcriptome. Genes Brain Behav :e12493|
|Ramey, Tatiana; Regier, Paul S (2018) Cognitive impairment in substance use disorders. CNS Spectr :1-12|
|Reilly, Sean W; Puentes, Laura N; Wilson, Khadija et al. (2018) Examination of Diazaspiro Cores as Piperazine Bioisosteres in the Olaparib Framework Shows Reduced DNA Damage and Cytotoxicity. J Med Chem 61:5367-5379|
|Shi, Zhenhao; Han, Shihui (2018) Distinct effects of reminding mortality and physical pain on the default-mode activity and activity underlying self-reflection. Soc Neurosci 13:372-383|
|Shi, Zhenhao; Wang, An-Li; Jagannathan, Kanchana et al. (2018) Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder. J Psychiatry Neurosci 43:254-261|
|Reilly, Sean W; Puentes, Laura N; Hsieh, Chia-Ju et al. (2018) Altering Nitrogen Heterocycles of AZD2461 Affords High Affinity Poly(ADP-ribose) Polymerase-1 Inhibitors with Decreased P-Glycoprotein Interactions. ACS Omega 3:9997-10001|
|Pierce, R Christopher; Fant, Bruno; Swinford-Jackson, Sarah E et al. (2018) Environmental, genetic and epigenetic contributions to cocaine addiction. Neuropsychopharmacology 43:1471-1480|
Showing the most recent 10 out of 45 publications